Theodore Alan Huizenga, SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 161 shares at $13.99 ($2K) on 2026-09-03, disclosed to the SEC on 2026-09-08.
Seasonal sale ($2k) by SVP, Chief Accounting Officer — this insider has traded RARE in September in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| RARE | SELL | 2025-12-30 | $3K | — | Filing → |
| RARE | SELL | 2025-09-19 | $2K | — | Filing → |
| RARE | SELL | 2025-09-08 | $3K | — | Filing → |